All Episodes

Welcome & Introduction: Regional Rounds Southeast: Ultra Rapid-acting Insulins for Pediatric PwD

Steven Haller, MD presents Ultra Rapid-Acting Insulin Analogues: Successes & Gaps in Pediatric PwDs

Steven Haller, MD, Mary Pat Gallagher, MD, Patrick Hanley, MD, Lori Laffel, MD, MPH, Kanika Shanker, MD, Michelle Van Name, MD present Clinical Consult Faculty Roundtable & Audience Questions Part 1

Steven Haller, MD, Mary Pat Gallagher, MD, Patrick Hanley, MD, Lori Laffel, MD, MPH, Kanika Shanker, MD, Michelle Van Name, MD present Clinical Consult Faculty Roundtable & Audience Questions Part 2

Steven Haller, MD, Mary Pat Gallagher, MD, Patrick Hanley, MD, Lori Laffel, MD, MPH, Kanika Shanker, MD, Michelle Van Name, MD present Clinical Consult Faculty Roundtable & Audience Questions Part 3

Regional Rounds Southeast: Ultra Rapid-acting Insulins for Pediatric PwD Close

Welcome & Introduction: Regional Rounds Northeast: Ultra Rapid-acting Insulins for Pediatric PwD

Steven Willi, MD presents Ultra Rapid-Acting Insulin Analogues: Successes & Gaps in Pediatric PwDs

Lori M. Laffel, MD, MPH presents A Breath of Fresh Air

Steven Willi, MD, Mary Pat Gallagher, MD, Patrick Hanley, MD, Lori Laffel, MD, MPH, Kanika Shanker, MD, Michelle Van Name, MD present Clinical Consult Faculty Roundtable & Audience Questions Part 1

Steven Willi, MD, Mary Pat Gallagher, MD, Patrick Hanley, MD, Lori Laffel, MD, MPH, Kanika Shanker, MD, Michelle Van Name, MD present Clinical Consult Faculty Roundtable & Audience Questions Part 2

Steven Willi, MD, Mary Pat Gallagher, MD, Patrick Hanley, MD, Lori Laffel, MD, MPH, Kanika Shanker, MD, Michelle Van Name, MD present Clinical Consult Faculty Roundtable & Audience Questions Part 3

Regional Rounds Northeast: Ultra Rapid-acting Insulins for Pediatric PwD Close

Welcome & Introduction: Regional Rounds West: Ultra Rapid-acting Insulins for Pediatric PwD

Laya Ekhlaspour, MD presents Ultra Rapid-Acting Insulin Analogues: Successes & Gaps in Pediatric PwDs

Lori M. Laffel, MD, MPH presents A Breath of Fresh Air

Laya Ekhlaspour, MD, Kathleen E. Bethin, MD, PhD, Gregory P. Forlenza, MD, Faisal Malik, MD, MSc, Roshanak Monzavi, MD present Clinical Consult Faculty Roundtable & Audience Questions Part 1

Laya Ekhlaspour, MD, Kathleen E. Bethin, MD, PhD, Gregory P. Forlenza, MD, Faisal Malik, MD, MSc, Roshanak Monzavi, MD present Clinical Consult Faculty Roundtable & Audience Questions Part 2

Laya Ekhlaspour, MD, Kathleen E. Bethin, MD, PhD, Gregory P. Forlenza, MD, Faisal Malik, MD, MSc, Roshanak Monzavi, MD present Clinical Consult Faculty Roundtable & Audience Questions Part 3

Regional Rounds West: Ultra Rapid-acting Insulins for Pediatric PwD Close

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP and Yael Mauer, MD, MPH, FACP, DABOM present Patient Perspectives of the PwD & MASH: MASH Management in PwD

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP, Yael Mauer, MD, MPH, FACP, DABOM and patients Diane and Heidi present Patient Perspectives of the PwD & MASH: Patient Perspectives

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP and Yael Mauer, MD, MPH, FACP, DABOM present Patient Perspectives of the PwD & MASH: Multidisciplinary MASH Management

Vivian A. Fonseca, MD, FRCP presents Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds Part 1

Lori M. Laffel, MD, MPH presents Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds Part 2

Lori M. Laffel, MD, MPH presents Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds Part 3

Vivian A. Fonseca, MD, FRCP and Lori M. Laffel, MD, MPH present Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds Part 4

Michael J. Haller, MD presents Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds Part 1

Michael J. Haller, MD presents Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds Part 2

Korey Hood, PhD and Michael J. Haller, MD present Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds Part 3

Julia Blanchette, PhD, RN, BC-ADM, CDCES presents Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds Part 1

Michael J. Haller, MD presents Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds Part 2

Julia Blanchette, PhD, RN, BC-ADM, CDCES and Michael J. Haller, MD present Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds Part 3

Irl B. Hirsch, MD, MACP and Carol J. Levy, MD, CDCES present Grand Rounds on: Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs.

Irl B. Hirsch, MD and David T. Ahn, MD present Grand Rounds on: Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs.

Arresting MASLD/MASH-Related Fibrosis Progression & Sequelae in PwD T2 Symposium at AACE '25

Irl B. Hirsch, MD and Desmond A Schatz, MD present Grand Rounds on: Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs.

Carol H. Wysham, MD, FACP presents MASLD/MASH in People with Diabetes: '24 Guidelines on Identification • Diagnosis • Management with Novel Therapies

Grazia Aleppo, MD, FACE and her patient Michael (PwD) present Ultra Rapid-acting Insulins: Patient Perspectives

Introduction to: Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds

Jennifer Sherr, MD, PhD presents Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds Part 1

Irl B. Hirsch, MD, MACP presents Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds Part 2

Irl B. Hirsch, MD, MACP and Jennifer Sherr, MD, PhD present Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs: Grand Rounds Part 3

Cari Berget, RN, MPH, CDCES presents DTR X: Addressing Real-world Barriers to Automated Insulin Delivery Adoption: Faculty Intros & Critical Need to Improve Access to/Utilize AID Systems

Cari Berget, RN, MPH, CDCES, Nicholas Argento, MD, Davida F. Kruger, MSN, APN-BC, BC-ADM and Shannon Boggs (PwD Caregiver) present DTR X: Addressing Real-world Barriers to Automated Insulin Delivery Adoption: Obstacles to AID System Consideration

Cari Berget, RN, MPH, CDCES, Nicholas Argento, MD, Davida F. Kruger, MSN, APN-BC, BC-ADM and Shannon Boggs (PwD Caregiver) present DTR X: Addressing Real-world Barriers to Automated Insulin Delivery Adoption: Obstacles to AID System Use/Persistence Part 1

Cari Berget, RN, MPH, CDCES, Nicholas Argento, MD, Davida F. Kruger, MSN, APN-BC, BC-ADM and Shannon Boggs (PwD Caregiver) present DTR X: Addressing Real-world Barriers to Automated Insulin Delivery Adoption: Obstacles to AID System Use/Persistence Part 2

Cari Berget, RN, MPH, CDCES presents DTR X: Addressing Real-world Barriers to Automated Insulin Delivery Adoption: Size and other Matters

Cari Berget, RN, MPH, CDCES, Nicholas Argento, MD and Davida F. Kruger, MSN, APN-BC, BC-ADM present DTR X: Addressing Real-world Barriers to Automated Insulin Delivery Adoption: Clinical Consult & YOUR Submitted Questions

Close DTR X: Addressing Real-world Barriers to Automated Insulin Delivery Adoption

Yogish C. Kudva, MD presents Mayo Clinic Grand Rounds: Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs Part 1

Irl B. Hirsch, MD, MACP presents Mayo Clinic Grand Rounds: Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs Part 2

Irl B. Hirsch, MD, MACP and Yogish C. Kudva, MD present Mayo Clinic Grand Rounds: Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs Part 3

Introduction to Deborah Kathleen Plante, MD. UC Davis Grand Rounds: Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs

Deborah Kathleen Plante, MD presents UC Davis Grand Rounds: Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs Part 1

Introduction to Irl B. Hirsch, MD, MACP. UC Davis Grand Rounds: Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs Introduction

Irl B. Hirsch, MD, MACP presents UC Davis Grand Rounds: Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs Part 2

Irl B. Hirsch, MD, MACP and Deborah Kathleen Plante, MD present UC Davis Grand Rounds: Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs Part 3

Viral Shah, MD and PwD Anna present Updates in Insulin Pumps & AID Systems - Compatible • Mobile • Predictive... Confidence: Patient Perspectives

Diana Isaacs PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP presents DTR IX: Updates in Insulin Pumps & AID Systems: Compatible • Mobile • Predictive... Confidence Part 1

Gregory P. Forlenza, MD presents DTR IX: Updates in Insulin Pumps & AID Systems: Compatible • Mobile • Predictive... Confidence Part 2

Gregory P. Forlenza, MD presents DTR IX: Updates in Insulin Pumps & AID Systems: Compatible • Mobile • Predictive... Confidence Part 3

Gregory P. Forlenza, MD and Diana Isaacs PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP present DTR IX: Updates in Insulin Pumps & AID Systems: Compatible • Mobile • Predictive... Confidence Part 4

Welcome & Housekeeping Introduction DTR X: Addressing Real-world Barriers to Automated Insulin Delivery Adoption

Prof Michael Roden, MD presents Worldwide Burden of NAFLD: Time for Action: Managing NAFLD and NASH in People with T2 Diabetes: Disease Burden • Diagnosis • Current & Emerging Armamentarium Part 1

Kenneth Cusi, MD, FACP, FACE presents Clinical Practice Guidelines for the Management of NAFLD: Understanding the Rationale for Screening 'High Risk' Patients: Managing NAFLD and NASH in People with T2 Diabetes: Disease Burden • Diagnosis • Current & Emerging Armamentarium Part 2

Juan Pablo Frías, MD presents Current Therapies and Novel Therapeutic Phase 3 Data: Managing NAFLD and NASH in People with T2 Diabetes: Disease Burden • Diagnosis • Current & Emerging Armamentarium Part 3

Davida F. Kruger, MSN, APN-BC, BC-ADMNP presents Case Studies in Screening, Diagnosis & Management of NAFLD and NASH: Managing NAFLD and NASH in People with T2 Diabetes: Disease Burden • Diagnosis • Current & Emerging Armamentarium Part 4

All Faculty present Audience Questions & Answers: Managing NAFLD and NASH in People with T2 Diabetes: Disease Burden • Diagnosis • Current & Emerging Armamentarium

Carol J. Levy, MD, CDCES presents: Part 1: ESSAeducation.net Grand Rounds Mount Sinai Hospital: Preconception Considerations for Higher Risk Individuals

Noel K. Strong, MD present: Part 2: ESSAeducation.net Grand Rounds Mount Sinai Hospital: Updates in Contraception with Emphasis on Caring for Women with Diabetes

Noel K. Strong, MD present: Part 3: ESSAeducation.net Grand Rounds Mount Sinai Hospital: Updates in Contraception with an Emphasis on Caring for Women with Diabetes

Noel K. Strong, MD present: Part 4: ESSAeducation.net Grand Rounds Mount Sinai Hospital: Updates in Contraception with an Emphasis on Caring for Women with Diabetes

NAFLD Part 1

NAFLD Part 2

NAFLD Part 3